The SLA technology is designed to help DoD personnel test items for illicit drug elements such as fentanyl or explosive compounds without disrupting the detector’s capacity to detect chemical agents, Smiths Detection said Thursday.
According to the company, SLA-equipped JCADs could support applications such as opioid detection and the identification of nontraditional chemical warfare agents.
Shan Hood, president of Smiths Detection, said the adapter uses current technology intended to extend the features and life cycle of currently deployed detection devices.
JCAD’s design is based on the company's product line of lightweight chemical detectors that military and law enforcement personnel use to identify toxic substances.
The Space Development Agency has awarded $3.5 billion in other transaction authority agreements to Lockheed Martin, L3Harris Technologies, Northrop Grumman…
The Defense Health Agency has awarded TriWest Healthcare Alliance $6.8 billion to continue providing healthcare and administrative services in support…